Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary.

Slides:



Advertisements
Similar presentations
Effects of oxygen, positive end-expiratory pressure, and carbon dioxide on oxygen delivery in an animal model of the univentricular heart  Christopher.
Advertisements

Volume 96, Issue 6, Pages (December 1989)
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Manuel J. Antunes, MD, PhD, DSc 
Effects of oxygen, positive end-expiratory pressure, and carbon dioxide on oxygen delivery in an animal model of the univentricular heart  Christopher.
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Surgery for congenital diseases of the aorta
Rounding numbers The Journal of Thoracic and Cardiovascular Surgery
Mitral stenosis with pulmonary hypertension: We should operate early
Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial.
Stephen Westaby, FRCS, MS, PhD, FETCS, FESC, FACC, FICA, Gabriele B
Coarctation Long-term Assessment (COALA): Significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated.
The surgical and interventional hybrid era: Experiences from China
Transplantation of initially rejected donor lungs after ex vivo lung perfusion  Andreas Wallinder, MD, Sven-Erik Ricksten, MD, PhD, Christoffer Hansson,
Right internal thoracic artery or saphenous vein grafting
Outcomes of surgery for young children with multivessel pulmonary vein stenosis  Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.
Pulmonary hypertension in valve disease: A beast of the past?
Hemoconcentration in ex vivo lung perfusion: A case report of a novel technique used in clinical lung transplantation  Andreas Wallinder, MD, Christoffer.
Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function
Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G
William M. DeCampli, MD, PhD 
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Cerebral oxygen delivery is reduced in newborns with congenital heart disease  Jessie Mei Lim, BSc, Theodore Kingdom, Brahmdeep Saini, BEng, Vann Chau,
Relationship between pulmonary arterial resistance and compliance among patients with pulmonary arterial hypertension and congenital heart disease  Jun.
The lord of the rings  Antonio Miceli, MD, PhD 
John S. Ikonomidis, MD, PhD, Ebony J
Bilateral lung transplantation and pulmonary artery reconstruction in a patient with chronic obstructive pulmonary disease and a giant pulmonary artery.
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Surgical indication for congenital heart disease with extremely thickened media of small pulmonary arteries  Shigeo Yamaki, MD, Ai Abe, MD, Masato Endo,
Support Your Specialty
Near-infrared spectroscopy: What we know and what we need to know—A systematic review of the congenital heart disease literature  Jennifer C. Hirsch,
A first start for lung transplantation?
Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis  Spencer J. Melby, MD, Marc R. Moon, MD, Brian R.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Leora B. Balsam, MD, Abe DeAnda, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Long-term survival in lung transplant recipients after successful preoperative coronary revascularization  Leonardo Seoane, MD, Lee M. Arcement, MD, Vincent.
Instrumental variable methods in clinical research
Reviewer Acknowledgment
Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease  Ronald W Day, MD, John A Hawkins, MD, Edwin C McGough,
Georg Matheis, MD, Friedhelm Beyersdorf, MD 
Nicorandil, a potent adenosine triphosphate–sensitive potassium-channel opener, ameliorates lung allograft reperfusion injury  Motohiro Yamashita, MD,
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Unilateral lung transplantation using right and left upper lobes: An experimental study  Hitoshi Nishikawa, MD, Takahiro Oto, MD, PhD, Shinji Otani, MD,
Volume 133, Issue 4, Pages (April 2008)
The harder one looks, the more one finds
Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: Clinical experience with 1400 cases  Yves Durandy, MD, Sylvie.
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
The continuing challenge of congenital heart disease in China
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm,
Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD 
Symptomatic neonates with Ebstein anomaly
Precise evaluation of bilateral pulmonary artery banding for initial palliation in high-risk hypoplastic left heart syndrome  Kazuo Kitahori, MD, PhD,
Why arch curvature affects arch resistance
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease  Ingram Schulze-Neick,
Apples remain apples NO matter what
George D. Lilly 1906–1988 Journal of Vascular Surgery
Energized lung resections
Preoperative PFTs: The answer is blowing in the wind
Who should decide margin length in pulmonary excision of lung cancer?
Edward Y. Chan, MD, Michael J. Reardon, MD 
Use of a low-resistance compliant thoracic artificial lung in the pulmonary artery to pulmonary artery configuration  Christopher N. Scipione, MD, Rebecca.
Presentation transcript:

Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance  Sohrab Fratz, MD, Ralf Geiger, MD, Hans Kresse, PhD, Gabriele Roemer, BS, Michael Hennig, PhD, Walter Sebening, MD, John Hess, MD, PhD, FESC  The Journal of Thoracic and Cardiovascular Surgery  Volume 126, Issue 6, Pages 1724-1729 (December 2003) DOI: 10.1016/S0022-5223(03)00937-1

Figure 1 Linear regression of mPAP (variable with greatest effect as assessed by multiple linear regression) and change of ET-1 concentration over pulmonary vascular bed of 56 patients with CHD and normal PVR. Positive change indicates increase of ET-1 concentration over pulmonary vascular bed; negative change indicates decrease. Change of ET-1 concentration was defined as ET-1 concentration in pulmonary vein minus ET-1 concentration in pulmonary artery divided by ET-1 concentration in pulmonary artery. Linear regression results (y = 2.1, x = 35.5, r2 = 0.409, P < .0001) seemed to be predominantly driven by patient in upper right corner. However, linear regression did not change considerably after exclusion of this patient. More importantly, when we repeated multiple linear regression analysis without this patient, highly significant results remained, as depicted in Table 1. Note that pulmonary vascular bed seems to be net ET-1 clearance site when mPAP is low (change is negative) and seems to shift to net ET-1 production site when mPAP is high (change is positive). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 1724-1729DOI: (10.1016/S0022-5223(03)00937-1)